Evidence map›Paper›PMID 41316195›Full record

SynthesisBMC endocrine disorders2025

Dysregulated iron metabolism related to ferroptosis in polycystic ovary syndrome: a meta-analysis and a case-control study in pregnant women.

Tianjing Wang, Weihuan Hu, Jue Zhou, Leyi Fu, Ningning Xie, Feng Yun, Jinlan Piao, Jing Lin, Danqing Chen, Fan Qu and 1 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tianjing Wang *Women's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Weihuan Hu *Women's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Jue ZhouCollege of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China.
Leyi FuWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Ningning XieWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Feng YunWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Jinlan PiaoWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Jing LinWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Danqing ChenWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China.
Fan QuWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China. syqufan@zju.edu.cn.
Fangfang WangWomen's Hospital, School of Medicine, Zhejiang University, 1 Xueshi Road, Hangzhou, 310006, China. drwangfangfang@zju.edu.cn.

Funding

National Key R&D Program of China 2024YFC3505800National Natural Science Foundation of China 81873837National Natural Science Foundation of China 82274564National Natural Science Foundation of China,China 82374510
6 · The paper itself

Abstract

backgroundFerroptosis, a type of cell death driven by iron metabolism, has been implicated in polycystic ovary syndrome (PCOS), although the evidence remains conflicting. This study aimed to comprehensively investigate the relationship between PCOS and ferroptosis-related iron metabolism, with a particular focus on its contribution to ferroptosis.

methodsWe performed a systematic review and meta-analysis including clinical studies from PubMed, Embase, and Web of Science up to November 2024 to analyse and compare the levels of serum ferritin, iron, hepcidin, and transferrin saturation levels between women with PCOS and the controls. Additionally, a case-control study on serum ferritin levels and placental expression of ferroptosis-related genes was conducted in 16 pregnant women with a prepregnancy diagnosis of PCOS and 21 controls, at Women’s Hospital, School of Medicine, Zhejiang University, China, in 2022.

resultsTwenty-two studies were included, and significant differences in serum ferritin levels were found between women with PCOS and controls (standardized mean difference (SMD): 0.86; 95% confidence intervals (CI): 0.40 to 1.32; P < 0.01). Moreover, serum iron (SMD: 0.46; 95% CI: 0.04 to 0.87; P = 0.03) and transferrin saturation (mean difference (MD): 4.85; 95% CI: 2.21 to 7.49; P < 0.01) levels were significantly greater in women with PCOS, whereas serum hepcidin levels were lower (SMD: -2.09; 95% CI: -3.30 to -0.87; P < 0.01). A case-control study revealed significantly elevated serum ferritin levels in the third trimester and notably upregulated expression of placental ferroptosis-related genes (ACSL4, TP53, GPX4, SLC7A11, and FTH1) at full term in the PCOS group compared with the control group.

conclusionOur findings highlight the involvement of ferroptosis-related dysregulation of iron metabolism in the pathophysiology of PCOS and suggest that altered placental ferroptosis is potentially linked to adverse pregnancy outcomes. Clinical health care providers should be more careful about decision-making concerning iron supplements for women with PCOS, especially pregnant individuals. Further work is needed to explore the regulatory mechanisms underlying iron metabolism in women with PCOS. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

FerroptosisIronPolycystic Ovary SyndromePregnancy ComplicationsCase-Control StudiesFemaleFerritinsHepcidinsHumansPregnancyFerritinsHepcidinsIronFerroptosisIron metabolismPolycystic ovary syndromePregnancy

Identifiers

PMID41316195
PMCPMC12763915

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.